Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing innovative products…
Japan focus: Otsuka Pharma, Yakult's gut health influence, pharmacovigilance and more
Recent developments in Japan's nutraceutical market…
AI Agents Find Their Footing in Healthcare and Pharma
Healthcare continues to be one of the most fruitful areas. Healthcare IT News reports that Dermatology Partners, a large dermatology group with 80 providers across 41 locations, is using agentic AI to handle a heavy flow of patient phone calls. The…
The $3,000 Dog Vaccine That Big Pharma Craves
We all need a feel-good story today. Headlines and social media are splattered with war, violence, and chaos — anything and everything that'll draw eyeballs to the view-whoring attention grabbing that has become our news cycle. Blood, death…
Pharmalittle: We're reading about Iran war's impact on pharma supply chain, a Pfizer Lyme vaccine, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-too-familiar routine of meetings, deadlines, and the like has returned with a vengeance. You knew this would…
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy?
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) gapped up prior to trading on Monday. The stock had previously closed at $19.11, but opened at $21.36. Ascentage Pharma Group International shares last traded at…
Amazon acquires Swiss delivery robot start-up Rivr
Rivr CEO Marko Bjelonic confirmed the acquisition in a post on LinkedIn but did not reveal any financial details. Investors included Amazon as well as Jeff Bezos through his investment company, according to the tech publication The Information.
22 stocks to watch: Pharma majors, Tata group, SBI, Kotak Mahindra Bank, Varroc, Thomas Cook, Vikram Solar
At least seven major drugmakers announced the launch of their generic versions of semaglutide on Saturday, the first day after the patent on semaglutide expired on Friday. Sun Pharmaceuticals, Zydus Lifesciences and Alkem announced a total of eight…
Here's Why Bruker's (BRKR) Positive Momentum Returned in Q4
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Strategy lagged the Russell Midcap Growth…
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
Novo lost semaglutide patent protection in India, triggering generic launches. Indian drugmakers launched generic versions at lower prices. Novo cut prices and used partnerships to defend market share in India. Nurphoto | Nurphoto | Getty Images…
Novartis Promises Growth Despite 'Historic' Patent Cliffs - I Broadly Agree (NYSE:NVS)
A few days ago (March 20th), Swiss Pharmaceuticals giant Novartis (NVS) announced it would pay $2bn up front (the deal may rise to $3bn if milestones are met) to acquire Pikavation Therapeutics, a wholly owned subsidiary of Synnovation, a privately…
Scientists discover Alzheimer's hidden 'death switch' in the brain
The harmful protein interaction involves two components previously studied: the NMDA receptor and the TRPM4 ion channel. NMDA receptors play an essential role in communication between nerve cells and are located on the cell surface, both at…
Thom Hartmann: A Message to MAGA Voters: You Got Played
Thom Hartmann is a veteran journalist who write The Hartmann Report, where this article appeared: I'm not writing this to mock you. I'm writing because you were lied to. And it wasn't by the people you were told to hate, but by the man you trusted…
The Best Stocks to Invest $1,000 in Right Now
High energy costs. High stock valuations. High volatility. It's enough to make an investor feel low. The good news is that there are still plenty of great stocks to buy despite the market uncertainty. I'm talking about investing in companies with…
'Well-positioned to navigate evolving landscape': Novo Nordisk India-chief
As the marketplace begins to see generic versions of semaglutide, in vials, pre-filled pens and tablets, to treat obesity and Type II diabetes – Danish healthcare company Novo Nordisk believes it is well placed to navigate this…
Receive a Daily briefing on Pharma Industry News
Get Started